Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108513 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL17003993 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL11213774 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL1780545 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL35912 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL6756329 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL304612 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL9931816 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| Hexane SCHEMBL6049081 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 | |
| SCHEMBL57407 | 1.00 | LMNA (0.65) | LMNATSHRTHRBEPHX1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 697 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | CHAN, Hardy Wai Hong (TW) | 2026-01-01 | — | — | US | claimed |
| CN-119331433-B | High-dispersibility phthalocyanine pigment and preparation method thereof | 淄博福颜化工集团有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119331433-A | High-dispersibility phthalocyanine pigment and preparation method thereof | 淄博福颜化工集团有限公司 | 2025-01-21 | — | — | CN | claimed |
| WO-2024263122-A1 | SUPERHYDROPHOBIC AND SUPEROLEOPHILIC COMPOSITE SPONGE MATERIAL AND THE PRODUCTION METHOD THEREOF | AKDENIZ UNIVERSITESI (TR) | 2024-12-26 | — | — | WO | claimed |
| CN-118547402-B | Para-aramid spinning oil and preparation method thereof | 烟台锐泽化学品有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118547402-A | Para-aramid spinning oil and preparation method thereof | 烟台锐泽化学品有限公司 | 2024-08-27 | — | — | CN | claimed |
| EP-4358119-A2 | IMPROVED SELF-ASSEMBLED MONOLAYER BLOCKING WITH INTERMITTENT AIR-WATER EXPOSURE | Applied Materials, Inc. (US) | 2024-04-24 | — | — | EP | claimed |
| CN-115926418-B | Chemical-resistant and high-temperature-resistant basalt fiber composite material | 四川衡耀复合材料科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-112239209-B | Drug delivery via pore-modified mesoporous silica nanoparticles | 奈力生医股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-117334560-A | Improved self-assembled monolayer blocking with intermittent air-water exposure | 应用材料公司 | 2024-01-02 | — | — | CN | claimed |
| WO-2013076035-A1 | MIXTURES, PARTICULARLY LOW IN VOLATILE ORGANIC COMPOUNDS (VOC), OF OLEFINICALLY FUNTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES | EVONIK DEGUSSA GMBH (DE) | 2013-05-30 | — | — | WO | claimed |
| WO-2013076032-A1 | LOW CHLORIDE COMPOSITIONS OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXYSILANES | EVONIK DEGUSSA GMBH (DE) | 2013-05-30 | — | — | WO | claimed |
| CN-102816463-A | Silane-containing pigment particles for electrophoretic display, electrophoretic fluid and electrophoretic display device | SIPIX IMAGING INC | 2012-12-12 | — | — | CN | claimed |
| CN-102015837-B | Sulfur modified silanes for the elaboration of high refractive index materials | ESSILOR INT | 2012-12-05 | — | — | CN | claimed |
| CN-102015837-A | Sulfur modified silanes for the elaboration of high refractive index materials | ESSILOR INT | 2011-04-13 | — | — | CN | claimed |
| US-20070087025-A1 | Reiteratively layered medical devices and method of preparing same | FITZHUGH ANTHONY | 2007-04-19 | — | — | US | claimed |
| CN-1681880-A | Organosilicon compounds and blends for treating silica | DOW CORNING (US) | 2005-10-12 | — | — | CN | claimed |
| CN-1681893-A | Hydrophobing silica with organosilicon compounds and blends thereof | DOW CORNING (US) | 2005-10-12 | — | — | CN | claimed |
| EP-1436018-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2004-07-14 | — | — | EP | claimed |
| WO-2003026717-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-04-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070087025-A1 | Reiteratively layered medical devices and method of preparing same | NOS2, NOS1, NOS3 | LMNA 2542/4885TSHR 2005/4885THRB 3599/4885 |
| US-20260000623-A1 | DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES | AQP4, ABCB1, SRMS | LMNA 1004/4885TSHR 3081/4885THRB 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.